| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 6,865 | $3.82 | $26,224.30 | -3.9% | +2.4% | +115.1% | |
| Dec 16, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 133 | $46.81 | $6,225.33 | -0.1% | -12.6% | -35.7% | |
| Dec 16, 2024 | PSNL Personalis, Inc. | Moore Stephen Michael52 | SVP And Chief Legal Officer | Sell | 1,513 | $3.82 | $5,779.66 | -2.2% | +2.4% | +115.1% | |
| Dec 16, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $76.75 | $805,994.80 | -12.9% | +17.3% | +76.0% | |
| Dec 16, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 4,834 | $3.82 | $18,465.88 | -3.8% | +2.4% | +115.1% | |
| Dec 16, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 3,728 | $76.75 | $286,139.28 | -11.7% | +17.3% | +76.0% | |
| Dec 16, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 26,123 | $28.72 | $750,296.13 | -4.0% | -30.5% | +35.6% | |
| Dec 13, 2024 | VCYT Veracyte, Inc. | Stapley Marc60 | Chief Executive Officer | Sell | 5,590 | $43.42 | $242,736.96 | -0.9% | -29.6% | -0.9% | |
| Dec 13, 2024 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 160,000 | $165.74 | $26,518,749.54 | -1.3% | -14.4% | +39.3% | |
| Dec 13, 2024 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 2,320 | $35.00 | $81,200.00 | -46.4% | +16.9% | +193.6% | |
| Dec 13, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 125,000 | $1.60 | $199,375.00 | - | +8.2% | -13.2% | |
| Dec 13, 2024 | PRPO Precipio, Inc. | Sandberg Richard A74 | Director | Buy | 15,000 | $5.80 | $87,000.00 | +331.5% | +19.2% | +328.9% | |
| Dec 13, 2024 | PRPO Precipio, Inc. | Sandberg Richard A74 | Director | Sell | 12,000 | $6.20 | $74,400.00 | -72.6% | +19.2% | +328.9% | |
| Dec 12, 2024 | PMDI Psychemedics Corp | Powell Anderson Capital Partners LLC | 10% Owner | Buy | 86,991 | $2.67 | $231,848.85 | +7.0% | - | - | |
| Dec 11, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 500,000 | $1.56 | $781,050.00 | +0.2% | +13.2% | -12.6% | |
| Dec 10, 2024 | NOTV Inotiv, Inc. | Brown Nigel | Director | Buy | 7,500 | $4.26 | $31,950.00 | +12.9% | -50.4% | -82.6% | |
| Dec 10, 2024 | PMDI Psychemedics Corp | Kamin Peter | - | Sell | 320,708 | $2.35 | $753,663.80 | -17.6% | - | - | |
| Dec 10, 2024 | NTRA Natera, Inc. | Chapman Rowan E52 | Director | Sell | 1,767 | $170.24 | $300,808.25 | -22.2% | -20.3% | +40.1% | |
| Dec 10, 2024 | NOTV Inotiv, Inc. | Beattie John Gregory | Chief Operating Officer | Buy | 30,000 | $4.75 | $142,500.00 | +22.8% | -50.4% | -82.6% | |
| Dec 9, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 4,858 | $166.59 | $809,312.19 | -4.1% | -21.0% | +40.4% | |
| Dec 9, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 1,137 | $76.37 | $86,835.87 | -4.4% | +23.1% | +120.7% | |
| Dec 9, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,661 | $76.37 | $279,597.53 | -5.5% | +23.1% | +120.7% | |
| Dec 9, 2024 | TMO Thermo Fisher Scientific Inc. | Chai Nelson46 | Director | Buy | 20 | $551.90 | $11,037.97 | - | -1.9% | +4.8% | |
| Dec 6, 2024 | NOTV Inotiv, Inc. | Harrington Michael J | Director | Buy | 10,000 | $3.98 | $39,822.00 | +36.4% | -30.0% | -78.7% | |
| Dec 6, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 367 | $52.70 | $19,342.37 | -0.3% | -25.7% | -38.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.